SCP2 and metabolic dysfunction-associated steatotic liver disease: In contrast to the protective effect of SCP2 on NAFLD, a previous study showed that SCP2 can promote the accumulation of low-density lipoprotein cholesterol (LDL-C), thereby promoting the development of atherosclerosis and hyperlipidemia [29].